工業富聯(601138.SH):擬使用不超476億元閒置自有資金購買理財產品和結構性存款
格隆匯3月22日丨工業富聯(601138.SH)公佈,公司董事會於2022年3月22日召開第二屆董事會第十九次會議,審議通過了《關於使用閒置自有資金購買理財產品和結構性存款的議案》,同意公司及公司子公司使用最高額度不超過476億元人民幣的閒置自有資金投資銀行、銀行理財子公司等金融機構發行的安全性高、流動性好、中短期(不超過一年)、保本的理財產品和結構性存款,在上述額度範圍內,資金可以滾動使用。
董事會授權公司管理層及財務部門在額度範圍內負責辦理購買理財產品及結構性存款的具體事宜,授權期限自本次董事會審議通過之日至公司2022年度董事會止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.